Repository Offers Clues About Young Adult Classical HL

Immune abnormalities persist in young adult classical Hodgkin lymphoma (YAcHL) patients long after cure. Yet, new research presented at the most recent Annual ASH Meeting and Exposition in New Orleans pointed out the difficulties in assessing whether those issues existed prior to diagnosis.

The doctor of the future will give no medicine

I took a deep, cleansing breath and calmly explained to the Pentagon officer that pain was as complex and varied as human cancer. No one approach would solve the issue consistently for every patient without unwanted and occasionally severe consequences. Needless to say, this was not the answer these leaders were looking for. We all left the meeting disappointed.

Hepatocellular Carcinoma Treatment, Survival Varies Among VA Regions

Veterans have higher rates of cirrhosis, hepatitis C infection, obesity, high alcohol use and diabetes—all of which put them at greater risk of hepatocellular carcinoma. Treatment is challenging, and a new study found that it tends to be inconsistent across regions within VA healthcare, with the West providing more interventions and having longer survival.